Home › Funds › TimesSquare Capital Management, LLC › RGEN

TimesSquare Capital Management, LLC position in RGEN

Repligen Corp · Health Care

TimesSquare Capital Management, LLC reported holding 397,389 shares of RGEN (Repligen Corp) in its Q3 2026 13F filing — a position valued at US$76.4M, representing 1.25% of its reported portfolio and ranking #22 among its reported holdings. TimesSquare Capital Management, LLC has disclosed RGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)397.39K sh
Reported value held$76.39M
Portfolio Weight1.25%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How TimesSquare Capital Management, LLC's RGEN position evolved

TimesSquare Capital Management, LLC first disclosed a stake in RGEN in Q3 2023 at 127,292 shares (US$20.2M). The position peaked in Q3 2026 at 397,389 shares, worth US$76.4M. Across 13 filings, TimesSquare Capital Management, LLC increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 397,389 shares valued at US$76.4M — a reduction of -49,575 shares quarter over quarter.. Notable position changes include a 62% increase in Q4 2023 (shares rose 2% over the following quarter), a 51% increase in Q3 2025 (shares rose 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 127.29K $20.24M New
Q4 2023 205.88K $37.02M Add
Q1 2024 194.07K $35.69M Reduce
Q2 2024 240.51K $30.32M Add
Q3 2024 275.63K $41.02M Add
Q4 2024 260.99K $37.57M Reduce
Q1 2025 235.99K $30.03M Reduce
Q2 2025 240.23K $29.88M Add
Q3 2025 362.13K $48.41M Add
Q4 2025 435.69K $71.39M Add
Q1 2026 456.08K $53.74M Add
Q2 2026 446.96K $60.98M Reduce
Q3 2026 397.39K $76.39M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (Repligen Corp) is a Health Care company. 32 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has TimesSquare Capital Management, LLC held RGEN?

TimesSquare Capital Management, LLC has disclosed RGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is TimesSquare Capital Management, LLC's current position in RGEN?

As of Q3 2026, TimesSquare Capital Management, LLC holds 397.39K shares of RGEN (Repligen Corp), valued at $76.39M, representing 1.25% of its reported portfolio and ranking #22.

Has TimesSquare Capital Management, LLC been buying or selling RGEN?

In the latest 13F filing (Q3 2026), TimesSquare Capital Management, LLC reduced its position in RGEN. The position peaked in Q3 2026 at 397.39K shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.